✦ LIBER ✦

Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.

✍ Scribed by T. Hedner; B. Persson; G. Berglund

Book ID: 117943363
Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 674 KB
Volume: 16
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1983.tb04974.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ketanserin in essential hypertension: us

Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.

✍ HA Cameron; PC Waller; LE Ramsay 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 819 KB

Long-term hemodynamic effects of ketanse

Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients

✍ Julio Vorobioff; Guadalupe Garcia-Tsao; Roberto Groszmann; Guillermo Aceves; Edu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Ketanserin, a 5-hydroxytryptamine-2 receptor blocker, has been shown to decrease portal pressure in recent acute hemodynamic studies that have been performed both in experimental animals and portal hypertensive patients. The present study was designed to investigate the effects of chronic oral admin

Effect of the 5-hydroxytryptamine type 2

Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.

✍ JR Zabludowski; C Zoccali; CG Isles; GD Murray; JI Robertson; GC Inglis; R Frase 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

The effect of ketanserin, a 5-HT2-recept

The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases

✍ J. De Cree; J. Leempoels; B. Demoen; V. Roels; H. Verhaegen 📂 Article 📅 1985 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 402 KB

Does a selective 5-hydroxytryptamine ant

Does a selective 5-hydroxytryptamine antagonist (ICI 169, 369) lower blood pressure in hypertensive patients?

✍ AK Scott; P. Roy-Chaudhury; J. Webster; JC Petrie 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

In vitro characterization of AR-A000002,

In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine1B autoreceptor antagonist

✍ Charlotte Ahlgren; Anders Eriksson; Pernilla Tellefors; Svante B. Ross; Carina S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 374 KB